Analysts Offer Insights on Healthcare Companies: Repare Therapeutics (RPTX) and Centene (CNC)
Centene Is Maintained at Buy by Truist Securities
Centene Price Target Raised to $93.00/Share From $91.00 by Barclays
Barclays Maintains Overweight on Centene, Raises Price Target to $93
Centene Price Target Cut to $85.00/Share From $95.00 by Oppenheimer
Centene Is Maintained at Outperform by Oppenheimer
Wells Fargo Maintains Centene(CNC.US) With Buy Rating, Raises Target Price to $76
Oppenheimer Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $85
A Quick Look at Today's Ratings for Centene(CNC.US), With a Forecast Between $73 to $93
Oppenheimer Reaffirms Their Buy Rating on Centene (CNC)
Analysts Are Bullish on These Healthcare Stocks: Medios AG (MEDOF), Centene (CNC)
Stephens Cuts Price Target on Centene to $73 From $75, Keeps Equalweight Rating
Truist Securities Adjusts Price Target on Centene to $84 From $89
UBS Upgrades Centene to Buy, Raises Price Target to $80
Centene Analyst Ratings
Centene's Undervaluation and Strategic Growth Positions: A Buy Recommendation by A.J. Rice
Centene Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Centene, Maintains $90 Price Target
Barclays Maintains Centene(CNC.US) With Buy Rating, Maintains Target Price $91
Centene (CNC) Receives a Buy From Barclays